Atlas Trials

Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease

Clinical trial NCT02843165 · COMPLETED

Trial details

NCT number
NCT02843165
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2016-09-02
Primary completion
2021-08-16
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.